期刊文献+

2型糖尿病患者代谢综合征组分与血管并发症相关性研究 被引量:5

Relationship of the metabolic syndrome(MS) and its components with diabetic vascular complications in type 2 diabetic patients
原文传递
导出
摘要 目的探讨2型糖尿病(T2DM)患者代谢综合征(MS)组分与糖尿病血管并发症的关联。方法 412例T2DM住院患者,按是否合并MS分为MS组和T2DM组,比较两组间糖尿病血管并发症相关指标的差异及其与MS组分的关联。结果 MS组心血管疾病(CVD)和糖尿病肾病(DN)的发病率明显高于T2DM组。多元逐步回归显示,HDL-C是颈动脉内中膜厚度的独立影响因素;平均动脉压、HDL-C和MS组分数是尿白蛋白排泄率的独立影响因素。结论 T2DM患者MS及其组分与CVD和DN相关。 Objective To investigate the relationship of metabolic syndrome (MS) and its components with diabetic vascular complications in type 2 diabetic patients. Methods The 412 type 2 diabetic patients were divided into two groups with (n=213) and without (n= 199)MS. The prevalence of diabetic vascular complications was compared between two groups. The correlations of the components of the metabolic syndrome with the level of urinary albumin excretion rate (UAER) and carotid artery intimamedia thickness (IMT) were analyzed. Results (1) The prevalence of cardiovascular disease(8. 1% vs 25.4%,P〈0.01) and diabetic nephropathy (44.2% vs 63.8%, P〈0. 01) was significantly higher in patients with MS than those without MS. (2) Multiple regression analysis demonstrated that HDL-C was an independent determinant of IMT(β=-0.01, P〈0. 05); and MAP, HDL-C and the number of MS components were independent determinants of UAER(β=0.12, P〈0. 05; β=-0. 16, P〈0.01; β=0. 15, P=0. 05). Conclusion MS and its components are associated with cardiovascular disease and diabetic nephropathy in type 2 diabetic patients.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第8期568-570,共3页 Chinese Journal of Diabetes
基金 国家自然科学基金资助项目(30700381) 上海市科委引领计划项目(74119638)
关键词 糖尿病 2型 代谢综合征 并发症 尿白蛋白排泄率 颈动脉内中膜厚度 Diabetes, type 2 Metabolic syndrome Complications Urinary albumin excretion rate Carotid artery intima-media thickness
  • 相关文献

参考文献5

  • 1Yokoyama H, Kuramitsu M, Kanno S, et al. Relationship be- tween metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular dis- ease or nephropathy. Diabetes Res Clin Pract, 2007, 75: 200-206.
  • 2SoneH, Mizuno S, FujiiH, et al. Is the diagnosis of metabol- ic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan DiabetesComplica- tions Study. Diabetes Care, 2005, 28:1463-1471.
  • 3赵琳,张霞,王颖,孙崴,张萍,苏本利.代谢综合征与2型糖尿病慢性并发症的相关性[J].中国糖尿病杂志,2008,16(5):271-273. 被引量:19
  • 4Costa LA, Canani LH, LisboaHR, et al. Aggregation of fea- tures of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med, 2004, 21:252-255.
  • 5Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol, 2007, 2:550-562.

二级参考文献4

  • 1Isomaa B, Almgren P, Tuoml T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001,24 : 683-689.
  • 2Costa LA, Canani LH, Lisboa HRK, et al. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med, 2004,21 :252-255.
  • 3Grundy SM, Brewer HB, James J, et al. Deftnition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/AmeriCan Heart Association conference on scientific issues related to definition. Arterioscler Thremb Vase Biol,2004, 24:13-18.
  • 4Isomaa B, Henricsson M, Almgren P, et al. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia, 2001,44 : 1148-1154.

共引文献18

同被引文献57

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部